Pregnancy and birth outcomes among vaccinated women
| Group I Agrippal S1 | Group II Grippol Plus | Group III Placebo | |
| Total subjects | 37 | 42 | 41 |
| Women | |||
| Physiological birth | 35 (94.6) | 39 (92.9) | 35 (85.4) |
| Miscarriage | 1 (2.7) | 1 (2.4) | 2 (4.9) |
| Premature birth | 1 (2.7) | 2 (4.8) | 4 (9.8) |
| Children | |||
| Without pathology | 34 (91.9) | 38 (90.5) | 33 (80.5) |
| With abnormalities or malformations | 1 (2.7) | 1 (2.4) | 2 (4.9) |
| Perinatal affection of CNS | 3 (8.1) | 4 (9.5) | 3 (7.3) |
| Intrauterine infection syndrome | 1 (2.7) | 2 (4.8) | 3 (7.3) |
Data are presented as n or n (%). Note that p>0.05 for the differences between the compared groups. CNS: central nervous system.